Velan Capital Investment Management LP — 13F Holdings

2026 Q3  ·  57 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Velan Capital Investment Management LP maintained a portfolio of 57 distinct positions. The most significant new addition was EDGEWISE THERAPEUTICS INC, now representing 1.33% of the total fund value. They heavily accumulated shares in EDESA BIOTECH INC, increasing the position by 54.9%. The fund also reduced its exposure to TENAX THERAPEUTICS INC by 87.5%.
Position History hover any row below to update
Loading…
Velan Capital Investment Management LP Alpharetta, GA Hedge Fund / Asset Manager AUM $105M
PCA Score Concentration Risk
Risk ENB
Total Positions
57
Quarter
2026 Q3
Top Holding
PRAX (21.3%)
Top 10 Concentration
79.8%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 57

Velan Capital Investment Management LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
PRAX
PRAXIS PRECISIO...
Healthcare 21.30% 18.10% #1
Prev: #1
6.5
—
-12,181 -13.7%
P
S
76,600 $22,308,218 2023 Q4 13F Filing 2026-09-30 2026-11-16
IMMX
IMMIX BIOPHARMA...
Healthcare 10.78% 6.81% #2 2
Prev: #4
6.5
—
no change no change
P
S
1,085,000 $11,289,425 2025 Q2 13F Filing 2026-09-30 2026-11-16
TARA
PROTARA THERAPE...
Healthcare 8.28% 6.62% #3 2
Prev: #5
5.3
—
no change no change
P
S
2,844,652 $8,676,189 2024 Q2 13F Filing 2026-09-30 2026-11-16
STRO
SUTRO BIOPHARMA...
Healthcare 7.84% 10.36% #4 1
Prev: #3
4.1
—
-2,122 -0.4%
P
S
510,038 $8,216,712 2024 Q4 13F Filing 2026-09-30 2026-11-16
ABVX
ABIVAX SA
Healthcare 6.20% 5.33% #5 1
Prev: #6
4.0
—
no change no change
P
S
65,630 $6,498,683 2025 Q3 13F Filing 2026-09-30 2026-11-16
MPLT
MAPLIGHT THERAP...
Healthcare 6.08% 10.76% #6 4
Prev: #2
4.9
—
131,810 26.7%
P
S
624,703 $6,365,724 2025 Q4 13F Filing 2026-09-30 2026-11-16
AVR
ANTERIS TECHNOL...
Healthcare 5.19% 4.20% #7 1
Prev: #8
3.1
—
no change no change
P
S
700,000 $5,439,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
EDSA
EDESA BIOTECH I...
Healthcare 5.15% 4.10% #8 1
Prev: #9
5.1
—
454,545 54.9%
P
S
1,282,045 $5,397,409 2025 Q1 13F Filing 2026-09-30 2026-11-16
AVTX
AVALO THERAPEUT...
Healthcare 4.75% 3.65% #9 2
Prev: #11
2.9
—
no change no change
P
S
324,452 $4,973,849 2024 Q4 13F Filing 2026-09-30 2026-11-16
XNCR
XENCOR INC
Healthcare 4.17% 2.50% #10 2
Prev: #12
1.7
—
-80,000 -31.4%
P
S
175,000 $4,366,250 2026 Q1 13F Filing 2026-09-30 2026-11-16
EVMN
EVOMMUNE INC
Healthcare 3.60% 3.65% #11 1
Prev: #10
1.9
—
5,000 1.1%
P
S
456,255 $3,768,666 2025 Q4 13F Filing 2026-09-30 2026-11-16
EPRX
EUPRAXIA PHARMA...
Healthcare 3.06% 1.42% #12 5
Prev: #17
2.2
—
no change no change
P
S
352,000 $3,203,200 2025 Q3 13F Filing 2026-09-30 2026-11-16
HRTX
HERON THERAPEUT...
Healthcare 2.62% 2.28% #13 1
Prev: #14
2.0
—
no change no change
P
S
8,753,290 $2,744,156 2022 Q4 13F Filing 2026-09-30 2026-11-16
EWTX
EDGEWISE THERAP...
Healthcare 1.33% — #14
Prev: #—
4.0
—
34,250 —
NEW
34,250 $1,390,550 2026 Q3 13F Filing 2026-09-30 2026-11-16
RNTX
REIN THERAPEUTI...
Healthcare 1.30% 1.08% #15 4
Prev: #19
1.5
—
no change no change
P
S
1,700,000 $1,366,800 2026 Q2 13F Filing 2026-09-30 2026-11-16
N/A
NASUS PHARMA LT...
Unknown 1.27% 0.77% #16 5
Prev: #21
1.5
—
no change no change
P
S
359,390 $1,326,149 — 13F Filing 2026-09-30 2026-11-16
QTTB
Q32 BIO INC
Healthcare 0.95% — #17
Prev: #—
3.9
—
120,000 —
NEW
120,000 $992,400 2026 Q3 13F Filing 2026-09-30 2026-11-16
NSPR
INSPIREMD INC
Healthcare 0.59% 0.06% #18 28
Prev: #46
3.2
—
776,542 524.2%
P
S
924,680 $617,501 2023 Q2 13F Filing 2026-09-30 2026-11-16
PTGX
PROTAGONIST THE...
Healthcare 0.50% 0.28% #19 6
Prev: #25
1.2
—
no change no change
P
S
3,700 $521,293 2025 Q2 13F Filing 2026-09-30 2026-11-16
AARD
AARDVARK THERAP...
Healthcare 0.43% — #20
Prev: #—
3.7
—
85,868 —
NEW
85,868 $452,524 2026 Q3 13F Filing 2026-09-30 2026-11-16
NRIX
NURIX THERAPEUT...
Healthcare 0.36% 0.24% #21 7
Prev: #28
1.1
—
no change no change
P
S
16,000 $379,360 2024 Q4 13F Filing 2026-09-30 2026-11-16
CTMX
CYTOMX THERAPEU...
Healthcare 0.31% 0.27% #22 4
Prev: #26
1.1
—
no change no change
P
S
120,000 $326,400 2024 Q4 13F Filing 2026-09-30 2026-11-16
OVID
OVID THERAPEUTI...
Healthcare 0.31% 0.21% #23 6
Prev: #29
1.1
—
no change no change
P
S
130,000 $323,700 2024 Q4 13F Filing 2026-09-30 2026-11-16
MLYS
MINERALYS THERA...
Healthcare 0.26% 0.18% #24 7
Prev: #31
1.1
—
no change no change
P
S
11,000 $276,430 2025 Q1 13F Filing 2026-09-30 2026-11-16
REPL
REPLIMUNE GROUP...
Healthcare 0.25% 0.13% #25 10
Prev: #35
1.1
—
no change no change
P
S
20,000 $264,800 2024 Q4 13F Filing 2026-09-30 2026-11-16
DTIL
PRECISION BIOSC...
Healthcare 0.24% 0.19% #26 4
Prev: #30
1.1
—
no change no change
P
S
40,000 $250,400 2025 Q3 13F Filing 2026-09-30 2026-11-16
ZLAB
ZAI LAB LTD
Healthcare 0.23% — #27
Prev: #—
3.6
—
9,000 —
NEW
9,000 $237,060 2026 Q3 13F Filing 2026-09-30 2026-11-16
CCCC
C4 THERAPEUTICS...
Healthcare 0.22% 1.62% #28 12
Prev: #16
0.1
—
-500,000 -87.7%
P
S
70,000 $233,100 2026 Q2 13F Filing 2026-09-30 2026-11-16
MGNX
MACROGENICS INC
Healthcare 0.22% 0.17% #29 3
Prev: #32
1.1
—
no change no change
P
S
60,000 $231,600 2026 Q1 13F Filing 2026-09-30 2026-11-16
IMNM
IMMUNOME INC
Healthcare 0.21% 0.13% #30 7
Prev: #37
1.1
—
no change no change
P
S
10,000 $215,100 2025 Q1 13F Filing 2026-09-30 2026-11-16
ANTX
AN2 THERAPEUTIC...
Healthcare 0.20% 0.12% #31 10
Prev: #41
1.1
—
no change no change
P
S
40,000 $212,800 2026 Q2 13F Filing 2026-09-30 2026-11-16
VRDN
VIRIDIAN THERAP...
Healthcare 0.20% 0.11% #32 10
Prev: #42
1.1
—
no change no change
P
S
10,000 $205,900 2025 Q2 13F Filing 2026-09-30 2026-11-16
CRBP
CORBUS PHARMACE...
Healthcare 0.20% 0.15% #33
Prev: #33
2.1
—
4,000 15.4%
P
S
30,000 $204,600 2024 Q3 13F Filing 2026-09-30 2026-11-16
ENTA
ENANTA PHARMACE...
Healthcare 0.19% — #34
Prev: #—
3.6
—
15,000 —
NEW
15,000 $197,700 2024 Q4 13F Filing 2026-09-30 2026-11-16
SCYX
SCYNEXIS INC
Healthcare 0.19% 0.10% #35 8
Prev: #43
1.1
—
no change no change
P
S
40,000 $197,600 2026 Q2 13F Filing 2026-09-30 2026-11-16
ARTV
ARTIVA BIOTHERA...
Healthcare 0.17% 0.15% #36 2
Prev: #34
1.1
—
no change no change
P
S
25,000 $178,000 2026 Q1 13F Filing 2026-09-30 2026-11-16
RCKT
ROCKET PHARMACE...
Healthcare 0.15% 0.12% #37 2
Prev: #39
1.1
—
no change no change
P
S
60,000 $157,800 2026 Q1 13F Filing 2026-09-30 2026-11-16
LYEL
LYELL IMMUNOPHA...
Healthcare 0.14% 0.90% #38 18
Prev: #20
0.1
—
-90,000 -85.7%
P
S
15,000 $146,850 2026 Q1 13F Filing 2026-09-30 2026-11-16
JBIO
JADE BIOSCIENCE...
Healthcare 0.13% — #39
Prev: #—
3.6
—
10,000 —
NEW
10,000 $140,500 2026 Q3 13F Filing 2026-09-30 2026-11-16
NMRA
NEUMORA THERAPE...
Healthcare 0.13% 0.24% #40 13
Prev: #27
1.1
—
no change no change
P
S
230,000 $137,126 2026 Q1 13F Filing 2026-09-30 2026-11-16
TENX
TENAX THERAPEUT...
CALL
CALL Option 0.12% 0.61% #41 17
Prev: #24
1.0
—
no change no change
P
S
68,700 $129,843 2024 Q3 13F Filing 2026-09-30 2026-11-16
LRMR
LARIMAR THERAPE...
Healthcare 0.10% 0.06% #42 6
Prev: #48
1.0
—
no change no change
P
S
33,000 $105,435 2024 Q4 13F Filing 2026-09-30 2026-11-16
KLRS
KALARIS THERAPE...
Healthcare 0.07% 0.06% #43 4
Prev: #47
1.0
—
no change no change
P
S
25,000 $72,250 2026 Q1 13F Filing 2026-09-30 2026-11-16
GOSS
GOSSAMER BIO IN...
Healthcare 0.00% 0.01%
Sold All 😨
(Was: #51)
0.0
—
-70,000 -100.0%
CLOSED
— $— 2023 Q3 13F Filing 2026-09-30 2026-11-16
CNTX
CONTEXT THERAPE...
Healthcare 0.00% 0.02%
Sold All 😨
(Was: #50)
0.0
—
-59,700 -100.0%
CLOSED
— $— 2024 Q2 13F Filing 2026-09-30 2026-11-16
PRQR
PROQR THRAPEUTI...
Healthcare 0.00% 0.05%
Sold All 😨
(Was: #49)
0.0
—
-45,000 -100.0%
CLOSED
— $— 2024 Q4 13F Filing 2026-09-30 2026-11-16
XLO
XILIO THERAPEUT...
Healthcare 0.00% 0.08%
Sold All 😨
(Was: #45)
0.0
—
-14,285 -100.0%
CLOSED
— $— 2025 Q4 13F Filing 2026-09-30 2026-11-16
QNRX
QUOIN PHARMACEU...
Healthcare 0.00% 0.10%
Sold All 😨
(Was: #44)
0.0
—
-32,372 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-16
KPTI
KARYOPHARM THER...
Healthcare 0.00% 0.12%
Sold All 😨
(Was: #40)
0.0
—
-20,000 -100.0%
CLOSED
— $— 2024 Q4 13F Filing 2026-09-30 2026-11-16
TECX
TECTONIC THERAP...
Healthcare 0.00% 0.13%
Sold All 😨
(Was: #38)
0.0
—
-6,000 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-16
Showing 1-50 of 57 holdings

Unlock Full Velan Capital Investment Management LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →